149 related articles for article (PubMed ID: 7758000)
1. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.
Resnicoff M; Abraham D; Yutanawiboonchai W; Rotman HL; Kajstura J; Rubin R; Zoltick P; Baserga R
Cancer Res; 1995 Jun; 55(11):2463-9. PubMed ID: 7758000
[TBL] [Abstract][Full Text] [Related]
2. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.
Resnicoff M; Burgaud JL; Rotman HL; Abraham D; Baserga R
Cancer Res; 1995 Sep; 55(17):3739-41. PubMed ID: 7641185
[TBL] [Abstract][Full Text] [Related]
3. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor I receptor: a key to tumor growth?
Baserga R
Cancer Res; 1995 Jan; 55(2):249-52. PubMed ID: 7812953
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
Rubin R; Baserga R
Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
[TBL] [Abstract][Full Text] [Related]
6. The IGF-I receptor protects tumor cells from apoptosis induced by high concentrations of serum.
Valentinis B; Baserga R
Biochem Biophys Res Commun; 1996 Jul; 224(2):362-8. PubMed ID: 8702396
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
8. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor.
Hongo A; Yumet G; Resnicoff M; Romano G; O'Connor R; Baserga R
Cancer Res; 1998 Jun; 58(11):2477-84. PubMed ID: 9622092
[TBL] [Abstract][Full Text] [Related]
10. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
11. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor.
Ambrose D; Resnicoff M; Coppola D; Sell C; Miura M; Jameson S; Baserga R; Rubin R
J Cell Physiol; 1994 Apr; 159(1):92-100. PubMed ID: 8138595
[TBL] [Abstract][Full Text] [Related]
12. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death.
Wu Y; Tewari M; Cui S; Rubin R
J Cell Physiol; 1996 Sep; 168(3):499-509. PubMed ID: 8816904
[TBL] [Abstract][Full Text] [Related]
13. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
14. Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts.
Nakamura S; Watanabe H; Miura M; Sasaki T
Exp Cell Res; 1997 Aug; 235(1):287-94. PubMed ID: 9281378
[TBL] [Abstract][Full Text] [Related]
15. Ethanol promotes cell death by inhibition of the insulin-like growth factor I receptor.
Cui SJ; Tewari M; Schneider T; Rubin R
Alcohol Clin Exp Res; 1997 Sep; 21(6):1121-7. PubMed ID: 9309326
[TBL] [Abstract][Full Text] [Related]
16. Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice.
Furlanetto RW; Harwell SE; Baggs RB
Cancer Res; 1993 Jun; 53(11):2522-6. PubMed ID: 8495414
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor.
Herzlieb N; Gallaher BW; Berthold A; Hille R; Kiess W
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):71-7. PubMed ID: 10726973
[TBL] [Abstract][Full Text] [Related]
19. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
Chernicky CL; Yi L; Tan H; Gan SU; Ilan J
Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344
[TBL] [Abstract][Full Text] [Related]
20. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
